The achievement didn't live up to the hype, but it has illuminated new areas of 'genetic dark matter'.
Academic rigor, journalistic flair
Articles on Gene editing
Displaying 1 - 20 of 85 articles
Using 'base editing', researchers have cured progeria in mice. This genetic syndrome causes premature ageing in humans – those with the disease usually don't live past the age of 13.
Plant scientists hope to avoid a repeat of the GM foods debate from two decades ago.
Jennifer Doudna and Emmanuelle Charpentier have been awarded the Nobel prize in Chemistry for their revolutionary work on 'gene scissors' that can edit DNA.
The tools to rewrite the genetic code to improve crops and livestock, or to treat genetic diseases, has revolutionized biology. A CRISPR engineer explains why this technology won the Nobel, and its potential.
Most scientific discoveries these days aren't easily ascribed to a single researcher. CRISPR is no different – and ongoing patent fights underscore how messy research can be.
Our approach to controversial technologies shouldn't be guided by scientists alone, nor by peddlers of misinformation on social media. A citizens' assembly could walk the line between the two.
The immune system is trained to destroy viruses, even when they carry therapeutic cargo as is the case in gene therapy. Now researchers have figured out how to dial down the immune response.
A person dies of opioid overdose once every 13 minutes in the US. A researcher proposes a way using existing technology to remove the opioid target in people to prevent overdoses.
Strategies to cure various types of blindness are looking more plausible after a series of recent breakthroughs using gene editing and gene therapy.
What criteria should be used to determine whether a food is natural? What if gene-editing techniques produce changes indistinguishable from those that evolve naturally? Is the food still natural?
One of the methods researchers are exploring to combat COVID-19 is gene editing: altering the genome of the virus to make it harmless.
The debate about gene editing will help shape the future of the human race. But how should the discussion get started?
One year after the first CRISPR babies were announced, changes in policies and regulations have meant that there have been no new CRISPR announcements since.
A number of things may have gone wrong when researchers edited Chinese twins Lulu and Nana's genome. Either way, the failed experiment is a cautionary tale for us all.
Ideas from economics might help us decide the most ethical way of using gene editing technology for human enhancement in the future.
In a new study, a team of US scientists have used gene editing to change the genetic code of white blood cells and transform them into more efficient tumor fighting cells. How did they do it?
CRISPR technology is continually improving to make it more specific, but serious consideration should be given to when and how CRISPR is safe for gene editing.
A growing international divide over cutting-edge medical research could worsen predatory practices, medical tourism and health inequality.
CRISPR technology could have momentous effects if it's used to edit genes that will be inherited by future generations. Researchers and ethicists continue to weigh appropriate guidelines.
Top contributors
-
Merlin Crossley is a Friend of The Conversation.Deputy Vice-Chancellor Academic and Professor of Molecular Biology, UNSW
-
Geneticist and Group Leader, The John Curtin School of Medical Research, Australian National University
-
Assistant Professor in Biomedical Ethics, National University of Singapore
-
Senior Lecturer, Queensland University of Technology
-
Research Professor, Philosophy, Dalhousie University
-
Visiting Professor in Biomedical Ethics, Murdoch Children's Research Institute; Distinguished Visiting Professor in Law, University of Melbourne; Uehiro Chair in Practical Ethics, University of Oxford
-
Doctoral Student in Biochemistry, University of Washington
-
Director of Research and Professor of Pathology, Dalhousie University
-
Vanier Scholar and Ph.D. Candidate in Microbiology and Immunology, Dalhousie University
-
Assistant Professor of Chemical Engineering, Herbert Wertheim College of Engineering, UF Health Cancer Center, University of Florida
-
Researcher, Lecturer, Attorney, University of KwaZulu-Natal
-
Deputy Director - Centre for Stem Cell Systems and Head of Engagements, Ethics & Policy Program, Stem Cells Australia, The University of Melbourne
-
Research Fellow in Biomedical Ethics, The University of Melbourne
-
Professor of Bioethics & Medicine, Sydney Health Ethics, Haematologist/BMT Physician, Royal North Shore Hospital and Director, Praxis Australia, University of Sydney
-
Associate Professor, Cumming School of Medicine, University of Calgary
